Individuals with gastrointestinal disorders like celiac disease, Crohn's disease, or surgical alterations in the gastrointestinal tract may also experience impaired B12 absorption
Most protocols dose by injection close to the site of injury (subcutaneous), though no human pharmacokinetic standard exists
Research Background Research on DSIP has explored its effects on sleep spindle activity, delta wave amplitude, and cortisol modulation
Mu Q, Kirby J, Reilly CM, Luo XM
Given the high curing potential, very safe profile (lethal dose not achieved), and with a suitably wide effective range (g-ng regimens) and unlimited methods of application (i.e., intraperitoneal, intragastric, in drinking water or topically, at the site of injury) (for review, see [1,3,4,5,6,8,9,32,33,34])), it may be a real challenge for further therapy